Biologist Matt Kaeberlein on Longevity Hype, Fasting, Rapamycin and Biological Age Tests
In this video description, biologist Matt Kaeberlein is presented as skeptical of direct-to-consumer longevity products and as questioning what data say about rapamycin and intermittent fasting; the description also lists topics such as biological age tests and the Dog Aging Project's rapamycin trial. [1]
Automatic summary · not editorially reviewed
The key findings
The description presents Matt Kaeberlein as a biologist of aging, Optispan's chief executive and a co-founder of the Dog Aging Project. [1]
A listed segment is titled "The Intermittent Fasting Myth: What Mouse Studies Show". [1]
The description lists a segment on whether Kaeberlein recommends rapamycin. [1]
The source at a glance
- Study type / format
- Video description of a podcast conversation; no study design is reported.
- Population / context
- Not reported in the description; the listed segments concern mice, dogs (Dog Aging Project) and general human longevity topics, but no study population is specified.
- Summary based on
- Creator description
- Original publication
- October 13, 2026
Kaeberlein's background and his 2024 resignation
The description introduces Matt Kaeberlein as a biologist of aging, chief executive of Optispan and co-founder of the Dog Aging Project. It also says he was founding director of the University of Washington's Healthy Aging and Longevity Research Institute and has published over 250 papers on longevity. The episode list includes a segment titled why he resigned from a longevity academy in 2024. The description gives no reason for the resignation and no further details about it.
Supporting source [1]
Skepticism toward longevity products and fasting claims
According to the description, Kaeberlein explains why direct-to-consumer longevity products deserve skepticism and how to spot longevity hype and misleading supplement claims. A listed segment is titled "The Intermittent Fasting Myth: What Mouse Studies Show", so the fasting discussion is framed around mouse studies. The description does not report what those mouse studies found, whether any human outcome was measured, or how large or long any study was. It also lists segments on lifespan versus healthspan and on whether aging has really been slowed.
Supporting source [1]
Rapamycin, the Dog Aging Project and biological age tests
The description lists segments asking what rapamycin is and whether it slows aging, plus a look inside the Dog Aging Project's rapamycin trial. It also lists a segment on whether Kaeberlein recommends rapamycin. The description does not state any trial result, dose, duration or whether the trial is in dogs or people beyond the project's name. Further segments cover protein intake and mTOR, whether biological age tests are accurate, one biological age clock he trusts, and how to spend 100 versus 1,000 dollars a month on longevity. No findings from these segments are reported in the description.
Supporting source [1]
How to interpret this
This explainer is based only on the video description. The video and transcript were not reviewed, so no findings, results, doses or study details beyond the description are reported. All substantive points are attributed to the description and its creator.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
Sean Kim · youtube.com · October 13, 2026